Safety and efficacy of non-insulin therapy in non-critically ill hospitalized patients with type 2 diabetes mellitus.


Journal

European journal of internal medicine
ISSN: 1879-0828
Titre abrégé: Eur J Intern Med
Pays: Netherlands
ID NLM: 9003220

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 22 04 2023
revised: 16 06 2023
accepted: 19 06 2023
medline: 23 10 2023
pubmed: 25 6 2023
entrez: 24 6 2023
Statut: ppublish

Résumé

Clinical guidelines recommend insulin as the mainstay of therapy for hospitalized patients with diabetes mellitus. The aim of the current study is to evaluate safety and efficacy of non-insulin anti-hyperglycemic therapy in hospitalized patients. Systematic review and meta-analysis of randomized controlled trials (RCTs) examining treatment of hospitalized patients with type 2 diabetes with insulin vs non-insulin therapy. We searched PubMed and the Cochrane Library for RCTs published from inception to November 30, 2022. Primary outcomes were 30-day mortality and hypoglycemic events during hospitalization. This meta-analysis includes two parts, the first is a comparison between insulin and non-insulin therapy and the second is a comparison between insulin only and a combination of insulin+non-insulin therapy. A total of 14 randomized control studies and 1570 patients were included. There was a lower incidence of 30-day mortality in the insulin+non-insulin group compared with the insulin group without statistical significance, RR 0.64 (95%CI 0.30-1.35). Hypoglycemic events were significantly lower with the non-insulin therapies compared to insulin therapy, RR 0.23 (95%CI 0.09-0.55). Mean daily glucose levels were significantly lower in the insulin+non-insulin group compared to the insulin group by 10.83 mg/dL (95%CI -14.78-(-6.87)). Non-insulin either with or without insulin, results in lower rates of hypoglycemia. Non-insulin+insulin is more effective than insulin alone in reducing blood glucose levels. Non-insulin-based therapy is safe and effective for control of hyperglycemia. Insulin combined with non-insulin drugs seems to be the preferred treatment option for the majority of hospitalized patients with type 2 DM in the non-critical care setting.

Identifiants

pubmed: 37355348
pii: S0953-6205(23)00213-3
doi: 10.1016/j.ejim.2023.06.018
pii:
doi:

Substances chimiques

Insulin 0
Hypoglycemic Agents 0
Blood Glucose 0

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-118

Informations de copyright

Copyright © 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare they have no conflict of interest.

Auteurs

Irit Ayalon-Dangur (I)

Institute of Endocrinology, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Tanya Babich (T)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Research Authority, Rabin Medical Center, Petah-Tikva, Israel.

Maayan Huberman Samuel (MH)

Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.

Leonard Leibovici (L)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Research Authority, Rabin Medical Center, Petah-Tikva, Israel.

Alon Grossman (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Medicine B, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel. Electronic address: along@clalit.org.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH